Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Julio del Río-Garma"'
Autor:
Jose Maria Garcia-Gala, Ramón Salinas, Javier de la Rubia, Gemma Mancebo Moreno, Cristina Pascual, José Antonio García-Erce, R. C. Gonzalez, Francisco Peña, Sonia A. Perez, Julio del Río-Garma, Cristina Arbona, Registro Español de la Púrpura Trombocitopénica Trombótica (Reptt), Aurora Viejo, Arturo Pereira, Maria Jesús Gomez, Jesús Martín-Sánchez, Ana Oliva, Faustino García-Candel, Laura Abril, Sabela Bobillo, Iñigo Romon, Monica Linares, Julia Vidan
Publikováno v:
ANNALS OF HEMATOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Despite the effectiveness of plasma exchange (PEX) and immunosuppressants in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP), a number of patients still die as a result of the disease. Whether caplacizumab could rescue these pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62662eb222932e2eae616761489d38bb
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11603
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11603
Autor:
Joan Cid, Inés Gómez Seguí, Rosa Goterris Viciedo, Julio del Río-Garma, Jorge M. Nieto, Luis M. Hernández Mateo, Elena Sebastián, A. González, Javier de la Rubia, Ramón Salinas, Teresa Fidalgo, Grupo Español de Aféresis, María Eva Mingot Castellano, David Valcarcel Ferreiras, Faustino García Candel, Cristina Pascual Izquierdo, Aurora Viejo Llorente, Hector Sarmiento Palao
Publikováno v:
Medicina Clínica. 158:630.e1-630.e14
Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy (TMA) characterized by the development of microangiopathic haemolytic anaemia, thrombocytopenia, and ischaemic organ dysfunction associated with ADAMTS13 levels lower than 10%
Autor:
Maria Cristina Pascual Izquierdo, Yolanda Martinez, Moraima Jiménez, Joan Cid, Aurora Viejo, Verónica Campuzano, Gemma Moreno Jiménez, David Valcárcel, Rosa Goterris, Miquel Lozano, Sandra Ortega, Ana Oliva, Luis Hernández, Sunil Lakhwani, Irene Garcia-Garcia, Jorge M. Nieto, Inmaculada Tallón, Saioa Zalba, Julio del Río-Garma, Miguel Fernández Zarzoso, Jon Ander Atucha Fernández, Maria Eva Mingot-Castellano, Inés Gómez-Seguí, Helena González, María Solé
Publikováno v:
Blood. 136:20-21
Introduction: Autoimmune thrombotic thrombocytopenic purpura (aTTP) is a severe disease caused by the production of autoantibodies against von Willebrand factor (vWF)-cleaving ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin-1 motifs
Publikováno v:
Blood transfusion = Trasfusione del sangue. 17(1)
Autor:
Angel Salgado, Cristina Amunarriz, M. Elena Moreno, Michael Calviño, Consuelo Martinez Redondo, Julio del Río-Garma, Margarita Berberana, Ana Oliva, Jose Garcia-Arroba, Gemma Mancebo Moreno, Rosa Goterris, Jesús Martín, Victoria Gonzalez, Jose Antonio Moreno, Faustino García-Candel, Luis Hernández, Julia Vidan, Jesus Fernandez-Sojo, Moreno M. Dolores, Carmen Fernandez, José Carlos Hernández, Aurora Viejo, Luisa Maria Guerra, Marina Gordillo, Joan Cid, Jose Maria Garcia-Gala, Nieves Alonso, M. Fernández, Melisa Daorta, Rafael Del Orbe, Maria Cristina Pascual Izquierdo, Sara Nistal Gil, Maite Calderon, Ramón Salinas, Javier de la Rubia, Maria Eva Mingot-Castellano, Sol Sanchez, Xavier Solanich, Esther Chica, Inés Gómez-Seguí, María Luisa Antelo, Carmen Ballester
Publikováno v:
Blood. 134:4910-4910
Introduction: Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease characterized by a severe deficiency of the enzymatic activity of ADAMTS13 caused by autoantibodies, with an incidence of 3-4 x106inhabitants per year according to th
Publikováno v:
Medicina Clínica. 136:534-540
Thrombotic thrombocytopenic purpura (TTP) is the most extensive and dangerous intravascular platelet clumping disorder. For more than a half-century after its initial recognition, mortality was near 100% and the etiology totally obscure. Then, in the
Autor:
Ramon Guardia, Javier de la Rubia, Miguel A. Sanz, Ana Sebrango, Francisco Peña, Guillermo Deben, Misericordia Pujol, Maria Jesús Gomez, Antonio Vidaller, Rafaela Lopez, Concepción Zamora, Julio del Río-Garma, Rosa Goterris, Federico Moscardó, Pilar Rodríguez
Publikováno v:
Transfusion and Apheresis Science. 43:299-303
Background Between 30% and 60% of patients with thrombotic thrombocytopenic purpura (TTP) relapse and mortality remains at 15–20%. Limited clinical data suggest that the administration of anti-CD20 antibody (rituximab) may be useful in preventing a
Autor:
Enric Contreras, Javier de la Rubia, Julio del Río-Garma, Maribel Díaz-Ricart, José María García-Gala, Miguel Lozano
Publikováno v:
Medicina clinica. 144(7)
Thrombotic microangiopathies (TMA) are disorders defined by the presence of a microangiopathic hemolytic anemia (with the characteristic hallmark of schistocytes in the peripheral blood smear), thrombocytopenia and organ malfunction of variable inten
Publikováno v:
Medicina clinica. 136(12)
Thrombotic thrombocytopenic purpura (TTP) is the most extensive and dangerous intravascular platelet clumping disorder. For more than a half-century after its initial recognition, mortality was near 100% and the etiology totally obscure. Then, in the
Autor:
José R. González-Porras, Julio del Río-Garma, José Antonio García-Erce, Alberto Alvarez-Larrán, Misericordia Pujol, Javier de la Rubia, Lourdes Enríquez, Ana G. Noblejas, Jose Maria Garcia-Gala, Cristina Arbona, Aurora Viejo, Arturo Pereira, Montserrat Borrell, Manuel Hernández-Jodrá
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2009, 88 (10), pp.973-978. ⟨10.1007/s00277-009-0707-9⟩
ANNALS OF HEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Annals of Hematology, Springer Verlag, 2009, 88 (10), pp.973-978. ⟨10.1007/s00277-009-0707-9⟩
ANNALS OF HEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International audience; The remission rate with plasma exchange (PE) in thrombotic thrombocytopenic purpura (TTP) exceeds 80%, but the disease relapses in up to 20–30% of the cases. Clinical characteristics and response to treatment of relapsed TTP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e19c5d754fd34aab575bc6910a4e20
https://hal.archives-ouvertes.fr/hal-00535035
https://hal.archives-ouvertes.fr/hal-00535035